$PODC
PodcastOne, Inc.

2024 Q1 Form 10-Q Financial Statement

#000143774924003801 Filed on February 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $11.71M $10.44M $8.590M
YoY Change 21.56% 6.05%
Cost Of Revenue $10.67M $9.387M $7.050M
YoY Change 33.15% 17.5%
Gross Profit $1.034M $1.055M $1.540M
YoY Change -31.49% -26.67%
Gross Profit Margin 8.83% 10.1% 17.93%
Selling, General & Admin $1.816M $3.333M $2.250M
YoY Change 48.13% -19.93%
% of Gross Profit 175.63% 315.92% 146.1%
Research & Development $15.00K $26.00K
YoY Change -42.31%
% of Gross Profit 1.42% 1.69%
Depreciation & Amortization $438.0K $100.0K $80.00K
YoY Change 25.0% -55.56%
% of Gross Profit 42.36% 9.48% 5.19%
Operating Expenses $2.212M $3.348M $2.270M
YoY Change 47.49% -23.05%
Operating Profit -$1.178M -$2.600M -$730.0K
YoY Change 256.16% -14.12%
Interest Expense $0.00 $0.00 -$1.480M
YoY Change -100.0% -414.89%
% of Operating Profit
Other Income/Expense, Net $184.0K $0.00 $140.0K
YoY Change -100.0% -128.0%
Pretax Income -$994.0K -$2.600M -$4.240M
YoY Change -38.68% 1015.79%
Income Tax $55.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.049M -$2.600M -$4.240M
YoY Change -38.68% 1015.79%
Net Earnings / Revenue -8.96% -24.9% -49.36%
Basic Earnings Per Share -$0.11 -$0.01
Diluted Earnings Per Share -$0.04 -$0.11 -$0.19
COMMON SHARES
Basic Shares Outstanding 23.15M 23.06M 148.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.445M $1.405M $3.970M
YoY Change -64.61%
Cash & Equivalents $1.445M $1.405M $3.562M
Short-Term Investments
Other Short-Term Assets $1.105M $402.0K $570.0K
YoY Change -29.47%
Inventory
Prepaid Expenses
Receivables $6.023M $7.816M $6.270M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.573M $9.623M $10.81M
YoY Change -25.09% -10.98%
LONG-TERM ASSETS
Property, Plant & Equipment $309.0K $309.0K $240.0K
YoY Change 27.69% 28.75%
Goodwill $12.04M $12.04M
YoY Change 0.0%
Intangibles $3.145M $3.052M
YoY Change 329.64%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $15.55M $18.05M $17.68M
YoY Change -7.33% 2.1%
TOTAL ASSETS
Total Short-Term Assets $8.573M $9.623M $10.81M
Total Long-Term Assets $15.55M $18.05M $17.68M
Total Assets $24.13M $27.68M $28.49M
YoY Change -14.53% -2.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.529M $1.546M $1.060M
YoY Change 45.85%
Accrued Expenses $5.854M $6.256M $5.220M
YoY Change 19.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $5.720M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.698M $10.93M $17.67M
YoY Change -63.53% -38.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $86.00K $276.0K
YoY Change
Total Long-Term Liabilities $86.00K $276.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.698M $10.93M $17.67M
Total Long-Term Liabilities $86.00K $276.0K $0.00
Total Liabilities $7.784M $11.21M $17.67M
YoY Change -63.12% -36.58%
SHAREHOLDERS EQUITY
Retained Earnings -$29.60M -$28.60M
YoY Change 133.7%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.34M $16.47M $10.82M
YoY Change
Total Liabilities & Shareholders Equity $24.13M $27.68M $28.49M
YoY Change -14.53% -2.86%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$1.049M -$2.600M -$4.240M
YoY Change -38.68% 1015.79%
Depreciation, Depletion And Amortization $438.0K $100.0K $80.00K
YoY Change 25.0% -55.56%
Cash From Operating Activities $425.0K $1.205M -$530.0K
YoY Change -327.36% -150.96%
INVESTING ACTIVITIES
Capital Expenditures $385.0K $291.0K $50.00K
YoY Change 482.0% -28.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$385.0K -$291.0K -$50.00K
YoY Change 482.0% -28.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 430.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 425.0K 1.205M -530.0K
Cash From Investing Activities -385.0K -291.0K -50.00K
Cash From Financing Activities 0.000 0.000 430.0K
Net Change In Cash 40.00K 914.0K -150.0K
YoY Change -709.33% -115.46%
FREE CASH FLOW
Cash From Operating Activities $425.0K $1.205M -$530.0K
Capital Expenditures $385.0K $291.0K $50.00K
Free Cash Flow $40.00K $914.0K -$580.0K
YoY Change -257.59% -159.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23122149
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23122149
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41795
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2503373
dei Entity Address Address Line1
EntityAddressAddressLine1
335 N. Maple Drive Suite 127
dei Entity Address City Or Town
EntityAddressCityOrTown
Beverly Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90210
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
858-0888
dei Security12b Title
Security12bTitle
Common stock, $0.00001 par value per share
dei Trading Symbol
TradingSymbol
PODC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23150136
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1405000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3562000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7816000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6876000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
402000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1006000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9623000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
11444000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
309000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
12041000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
12041000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3052000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
732000 usd
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
2650000 usd
CY2023Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
3768000 usd
CY2023Q4 us-gaap Assets
Assets
27675000 usd
CY2023Q1 us-gaap Assets
Assets
28227000 usd
CY2023Q4 us-gaap Bridge Loan
BridgeLoan
0 usd
CY2023Q1 us-gaap Bridge Loan
BridgeLoan
7155000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4767000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10930000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21108000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
276000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
11206000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
21108000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45031000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19785000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28562000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12666000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16469000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7119000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27675000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28227000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10442000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8589000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31595000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25802000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9387000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7045000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26666000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19954000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
732000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1115000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3433000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3931000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
134000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2601000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1111000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4736000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2723000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
307000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
523000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
76000 usd
CY2023Q4 us-gaap Costs And Expenses
CostsAndExpenses
13042000 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
9322000 usd
us-gaap Costs And Expenses
CostsAndExpenses
35428000 usd
us-gaap Costs And Expenses
CostsAndExpenses
26818000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2600000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-733000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3833000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1016000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
-0 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
1661000 usd
us-gaap Interest Expense
InterestExpense
2247000 usd
us-gaap Interest Expense
InterestExpense
3043000 usd
CY2023Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2022Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-178000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7603000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1043000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1345000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9850000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2600000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2078000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13683000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3016000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-2600000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2078000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13683000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3016000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23072179
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147984230
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21252375
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147984230
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7119000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-210000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6993000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
842000 usd
CY2023Q3 podc Adjustments To Additional Paid In Capital Common Stock Warrants Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalCommonStockWarrantsReclassifiedToEquity
9116000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10276000 usd
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
-0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
12000 usd
CY2023Q3 podc Stock Issued During Period Value Purchase Of Intangibles
StockIssuedDuringPeriodValuePurchaseOfIntangibles
917000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10873000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
17283000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1663000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-2600000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16469000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13085000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
286000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-481000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12890000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-457000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
12733000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
165000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2078000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10820000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13683000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3016000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
710000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
241000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2724000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
751000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1949000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2641000 usd
podc Change In Fair Value Of Bifurcated Embedded Derivatives
ChangeInFairValueOfBifurcatedEmbeddedDerivatives
7603000 usd
podc Change In Fair Value Of Bifurcated Embedded Derivatives
ChangeInFairValueOfBifurcatedEmbeddedDerivatives
-1043000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-126000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
814000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1727000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-604000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1958000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-4909000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
583000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-711000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
278000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1786000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4348000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
255000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
162000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
688000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-943000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-162000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3000000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
-0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Advertising Expense
AdvertisingExpense
100000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
7376000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7376000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2157000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2866000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3562000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1103000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1405000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3969000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Stock Issued1
StockIssued1
917000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1241000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
10276000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
podc Common Stock Dividend
CommonStockDividend
2213000 usd
podc Common Stock Dividend
CommonStockDividend
0 usd
podc Warrants Classified From Liability To Equity
WarrantsClassifiedFromLiabilityToEquity
9116000 usd
podc Warrants Classified From Liability To Equity
WarrantsClassifiedFromLiabilityToEquity
0 usd
podc Derivative Exchanged Into Common Stock
DerivativeExchangedIntoCommonStock
3254000 usd
podc Derivative Exchanged Into Common Stock
DerivativeExchangedIntoCommonStock
0 usd
podc Fair Value Of Warrant And Derivative Liability Issued With Debt Instrument
FairValueOfWarrantAndDerivativeLiabilityIssuedWithDebtInstrument
0 usd
podc Fair Value Of Warrant And Derivative Liability Issued With Debt Instrument
FairValueOfWarrantAndDerivativeLiabilityIssuedWithDebtInstrument
4308000 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
16100000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1400000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28600000 usd
CY2023Q4 podc Working Capital
WorkingCapital
1300000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the Company’s interim unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, the fair value of the Company’s equity-based compensation awards and convertible debt and debt instruments, fair values of derivatives, and contingencies. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. Given the overall uncertainty surrounding the COVID-<em style="font: inherit;">19</em> pandemic, there is a reasonable possibility that actual results could differ from those estimates and such differences could be material to the financial position and results of operations, specifically in assessing when the collectability of revenue related consideration is probable, and the impairment assessment of goodwill, indefinite lived assets or long-lived assets that are depreciated or amortized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3969000 usd
CY2023Q4 us-gaap Advertising Expense
AdvertisingExpense
100000 usd
CY2022Q4 us-gaap Advertising Expense
AdvertisingExpense
100000 usd
us-gaap Advertising Expense
AdvertisingExpense
100000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1405000 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7876000 usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7062000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
60000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
186000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
7816000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
6876000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
964000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
710000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
655000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
468000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
309000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
100000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
100000 usd
us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
100000 usd
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 pure
CY2023Q1 us-gaap Goodwill
Goodwill
12041000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
12041000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
6898000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4625000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1573000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3052000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1782000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1050000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
732000 usd
CY2023Q4 podc Finders Fee Payment Capitalized
FindersFeePaymentCapitalized
2200000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
748000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1480000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
199000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
199000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
199000 usd
CY2023Q4 podc Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
227000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3052000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1546000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1541000 usd
CY2023Q4 podc Accrued Revenue Share
AccruedRevenueShare
3925000 usd
CY2023Q1 podc Accrued Revenue Share
AccruedRevenueShare
3039000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2331000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2318000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
7802000 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1400000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2600000 usd
CY2022Q4 podc Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue
700000 usd
CY2023Q4 podc Warrants Embedded Redemption Liability Derivative And Fees
WarrantsEmbeddedRedemptionLiabilityDerivativeAndFees
5800000 usd
CY2023Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1600000 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
600000 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
7000000 usd
CY2022Q4 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
9800000 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
7000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
5000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
1 pure
us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.05 pure
CY2023Q4 podc Common Stock Shares Cancelled
CommonStockSharesCancelled
127984230
CY2022Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
110000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
240000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.2
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
155000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.86
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
128750
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y10M17D
CY2023Q4 podc Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue
300000 usd
CY2023Q4 podc Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue
100000 usd
CY2022Q4 podc Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue
200000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
110000000

Files In Submission

Name View Source Status
0001437749-24-003801-index-headers.html Edgar Link pending
0001437749-24-003801-index.html Edgar Link pending
0001437749-24-003801.txt Edgar Link pending
0001437749-24-003801-xbrl.zip Edgar Link pending
ex_613083.htm Edgar Link pending
ex_613084.htm Edgar Link pending
ex_613085.htm Edgar Link pending
ex_613086.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
podc-20231231.xsd Edgar Link pending
podc20231231_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
podc-20231231_def.xml Edgar Link unprocessable
podc-20231231_lab.xml Edgar Link unprocessable
podc-20231231_pre.xml Edgar Link unprocessable
podc20231231_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
podc-20231231_cal.xml Edgar Link unprocessable